OPKO Health Inc OPK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
-
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
-
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
-
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
-
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
-
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
Trading Information
- Previous Close Price
- $1.66
- Day Range
- $1.60–1.66
- 52-Week Range
- $0.98–1.77
- Bid/Ask
- $1.60 / $1.65
- Shares Outstanding
- 746.33M
- Market Cap
- $1.19B
- Volume/Avg
- 2M / 4M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 3.76%
Company Profile
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,275
- Website
- https://www.opko.com
Valuation
|
Metric
|
OPK
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.05 |
Price/Sales | 2.20 |
Price/Cash Flow | — |
Price/Earnings
OPK
Financial Strength
|
Metric
|
OPK
|
|---|---|
Quick Ratio | 2.78 |
Current Ratio | 3.35 |
Interest Coverage | −1.06 |
Quick Ratio
OPK
Profitability
|
Metric
|
OPK
|
|---|---|
Return on Assets (Normalized) | −8.96% |
Return on Equity (Normalized) | −13.72% |
Return on Invested Capital (Normalized) | −8.65% |
Return on Assets
OPK
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|^Bhl!%#$ | LOCK|dk | $257B | |||
| Danaher Corp
DHR
| LOCK|DL?&T<? | LOCK|#>b | $164B | |||
| Agilent Technologies Inc
A
| LOCK|VB$yC@j> | LOCK|Fl | $50B | |||
| Waters Corp
WAT
| LOCK|Vlkp$@ | LOCK|g^ | $45B | |||
| IQVIA Holdings Inc
IQV
| LOCK|F%w%C@ | LOCK|ph@H | $44B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|RPB!mk$^ | LOCK|HT@ | $44B | |||
| Illumina Inc
ILMN
| LOCK|&$x$km | LOCK|#&^% | $43B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|??Qz$v! | LOCK|F&V>< | $34B | |||
| Quest Diagnostics Inc
DGX
| LOCK|zPwwbS | LOCK|Rf%Jk | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|R!qn%D? | LOCK|&sHJ | $26B |
United States